Pilbara Minerals share price on watch amid 78% half-year profit decline and no dividend

Weak lithium prices have weighed heavily on the company's profits.

| More on:
A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pilbara Minerals Ltd (ASX: PLS) share price will be in focus today.

This follows the release of the lithium miner's eagerly anticipated half-year results.

Pilbara Minerals share price on watch

  • Revenue down 65% to $757 million (from $2,180 million)
  • EBITDA down 77% to $415 million (from $1,812 million)
  • Underlying profit after tax down 78% to $273 million (from $1,242 million)
  • No interim dividend for FY 2024
  • Cash balance of $2.1 billion

What happened during the half?

For the six months ended 31 December, Pilbara Minerals reported a sharp drop in both revenue and profits.

The company's revenue was down 65% to $757 million after a 67% reduction in its average realised price offset a 7% lift in sales volumes.

Things were even worse for Pilbara Minerals' earnings, with EBITDA falling 77% to $415 million and its underlying profit after tax dropping 78% to $273 million.

In light of this profit decline, the company's board elected not to pay an interim dividend for FY 2024.

Management commentary

Pilbara Minerals CEO, Dale Henderson, was pleased with the result given the tough trading conditions. He said:

The first half of the financial year represents a strong set of operational outcomes and successful project milestones that continue to advance the Company's growth strategy as an emerging lithium materials leader.

Strong EBITDA margins of 55% were delivered during the period despite the softer pricing environment for lithium. Although pricing has reduced significantly from the prior year record highs, the Company finds itself in a position of strength. Our strong balance sheet positions the business to navigate any period of softer pricing and provides a competitive advantage relative to many peers within the sector.

Commenting on the company's decision not to pay a dividend, the CEO said:

To further reinforce the balance sheet, prudent steps were undertaken to further preserve capital including the decision to withhold any interim dividend payment.

Outlook

Henderson remains positive on the future, noting that the company's low costs leave it well-positioned in the current environment. He said:

With the Company's low unit-cost structure and strong balance sheet, Pilbara Minerals is uniquely placed to better withstand periods of softer pricing whilst continuing to build-out the production base to capitalise on improved pricing conditions.

Management also advised that its FY 2024 capital expenditure guidance is down slightly to $820 million to $875 million.

The Pilbara Minerals share price is down 14% over the last 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop2
Earnings Results

Dyno Nobel posts lower loss as transformation accelerates after fertilisers exit

Dyno Nobel trimmed its loss as underlying profit and dividends rose, with explosives now its sole focus after the fertilisers…

Read more »

Company's CEO at a meeting with workers talking about earnings results.
Earnings Results

ANZ Group Holdings' FY25 profit dips but dividend holds steady

ANZ Group Holdings’ FY25 profit fell but dividends remained steady, with underlying performance flat excluding significant items.

Read more »

A female financial services professional with a manicured black afro hairstyle turns an ipad screen to show a client across the table a set of ASX shares figures in graph format.
Earnings Results

Macquarie shares slump 7% on half-year earnings miss

Let's see how the investment bank performed during the first half.

Read more »

two men raise their fists and shout with their mouths wide open on a sofa as though they are watching sport or something stirring on a television that is out of picture.
Earnings Results

Nine Entertainment flags digital growth and more cost cuts in FY26 update

Nine Entertainment has reported upbeat digital subscription growth and expects further EBITDA gains, despite a tough ad market in FY26.

Read more »

A woman wearing a hat, sunglasses and a bathing suit reads the newspaper while sitting on a lounging chair that's placed in a pool in a relaxing setting.
Earnings Results

News Corporation Q1 FY26: Digital-led growth, higher buybacks

News Corporation lifted Q1 FY26 revenue and EBITDA, fuelled by digital growth and a strong performance from Dow Jones.

Read more »

A typical Australian family of mother, father, and two kids stands outside their modest but homely Australian suburban home complete with green grass, outdoor plants and furniture.
Earnings Results

REA Group share price on watch after Q1 FY26 results show growth in revenue and yield

REA Group delivered Q1 FY26 revenue growth and record audience, as its share price responds to the latest earnings results.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Earnings Results

Macquarie Group posts higher 1H26 profit and ups dividend

Macquarie Group delivered higher first-half profit and revenue, declared an interim dividend, and flagged cautious optimism amid mixed conditions.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Neuren Pharmaceuticals Q3 2025: Record DAYBUE sales fuel robust growth

Neuren Pharmaceuticals reported record DAYBUE sales and royalties in Q3 2025, with expanding US and international demand.

Read more »